Entry |
|
Name |
Nilutamide (USAN/INN); Nilandron (TN) |
Product |
|
Generic |
|
Formula |
C12H10F3N3O4
|
Exact mass |
317.0623
|
Mol weight |
317.2207
|
Structure |
|
Simcomp |
|
Class |
Antineoplastic
DG01591 Androgen receptor antagonist
DG01624 Flutamide-type antiandrogen
|
Remark |
|
Efficacy |
Antineoplastic, Androgen receptor antagonist |
Disease |
|
Target |
|
Pathway |
|
Network |
|
Structure map |
map07226 | Progesterone, androgen and estrogen receptor agonists/antagonists |
|
Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L02 ENDOCRINE THERAPY
L02B HORMONE ANTAGONISTS AND RELATED AGENTS
L02BB Anti-androgens
L02BB02 Nilutamide
D00965 Nilutamide (USAN/INN) <US>
USP drug classification [BR:br08302]
Antineoplastics
Antiandrogens
Nilutamide
D00965 Nilutamide (USAN/INN)
Drug groups [BR:br08330]
Antineoplastic
DG01591 Androgen receptor antagonist
DG01624 Flutamide-type antiandrogen
D00965 Nilutamide
Drug classes [BR:br08332]
Antineoplastic
DG01591 Androgen receptor antagonist
D00965 Nilutamide
Target-based classification of drugs [BR:br08310]
Nuclear receptors
Estrogen like receptors
3-Ketosteroid receptor
NR3C4 (AR)
D00965 Nilutamide (USAN/INN) <US>
|
Other DBs |
|
KCF data |
ATOM 22
1 N1y N 34.9300 -18.0600
2 C8y C 36.1200 -18.7600
3 C5x C 33.7400 -18.8300
4 C5x C 34.5800 -16.6600
5 C8x C 36.1200 -20.1600
6 C8x C 37.3800 -18.0600
7 C1z C 32.6900 -17.9200
8 O5x O 33.7400 -20.2300
9 N1x N 33.1800 -16.6600
10 O5x O 35.5600 -15.6800
11 C8x C 37.3800 -20.8600
12 C8y C 38.5700 -18.7600
13 C1a C 31.7100 -16.9400
14 C1a C 31.5000 -18.6200
15 C8y C 38.5700 -20.1600
16 N2b N 39.7600 -20.8600 #+
17 O3a O 39.7600 -22.2600
18 O3a O 41.0200 -20.1600 #-
19 C1d C 39.7853 -18.0649
20 X F 40.9977 -17.3649
21 X F 39.0853 -16.8525
22 X F 40.4853 -19.2774
BOND 23
1 1 2 1
2 1 3 1
3 1 4 1
4 2 5 2
5 2 6 1
6 3 7 1
7 3 8 2
8 4 9 1
9 4 10 2
10 5 11 1
11 6 12 2
12 7 13 1
13 7 14 1
14 11 15 2
15 15 16 1
16 16 17 2
17 16 18 1
18 7 9 1
19 12 15 1
20 12 19 1
21 19 20 1
22 19 21 1
23 19 22 1
|